John E. Mullinax

Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial

Ben Creelan, Chao Wang, Jamie K. Teer et al. · Nature Medicine · 2021 · 400 citations · Full text

Tumor-infiltrating Lymphocyte Treatment, Cancer Immunosurveillance, Medicine +10

Tumor interferon signaling and suppressive myeloid cells are associated with CAR T-cell failure in large B-cell lymphoma

Michael D. Jain, Hua Zhao, Xuefeng Wang et al. · Blood · 2021 · 273 citations · Full text

Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: Results of the GYMSSA trial

Udo Rudloff, Russell C. Langan, John E. Mullinax et al. · Journal of Surgical Oncology · 2014 · 227 citations · Full text

Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group

Carol J. Swallow, Sylvie Bonvalot, Piotr Rutkowski et al. · Annals of Surgical Oncology · 2021 · 224 citations · Full text

Surgical Oncology, Primary Retroperitoneal Sarcoma, Surgical Pathology +4

Label-retaining liver cancer cells are relatively resistant to sorafenib

Hong-Wu Xin, Chenwi M. Ambe, Danielle M. Hari et al. · Gut · 2013 · 107 citations · Full text